ATE473995T1 - Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung - Google Patents

Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Info

Publication number: ATE473995T1
Authority: AT; Austria
Prior art keywords: angiotensin; analogue; wound healing; tissue recovery; analogs
Prior art date: 1993-09-24

Application number

AT02028323T

Other languages

English (en)

Inventor

Kathleen Elizabeth Rodgers

Gere Stodder Dizerega

Original Assignee

Univ Southern California

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-24

Filing date

1994-09-19

Publication date

2010-07-15

1994-09-19 Application filed by Univ Southern California filed Critical Univ Southern California

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE473995T1 publication Critical patent/ATE473995T1/de

Links

CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical class C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 title abstract 2
238000011084 recovery Methods 0.000 title 1
230000029663 wound healing Effects 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 2
102000005862 Angiotensin II Human genes 0.000 abstract 1
101800000733 Angiotensin-2 Proteins 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
229950006323 angiotensin ii Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/14—Angiotensins: Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Vascular Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Materials For Medical Uses (AREA)

AT02028323T 1993-09-24 1994-09-19 Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung ATE473995T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US12637093A	1993-09-24	1993-09-24

Publications (1)

Publication Number	Publication Date
ATE473995T1 true ATE473995T1 (de)	2010-07-15

Family

ID=22424466

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02028323T ATE473995T1 (de)	1993-09-24	1994-09-19	Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung

Country Status (9)

Country	Link
US (1)	US5716935A (de)
EP (2)	EP1333034B1 (de)
JP (1)	JPH09503205A (de)
AT (1)	ATE473995T1 (de)
AU (1)	AU697504B2 (de)
CA (1)	CA2172494A1 (de)
DE (1)	DE69435301D1 (de)
WO (1)	WO1995008565A1 (de)
ZA (1)	ZA947337B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5902790A (en) *	1995-10-03	1999-05-11	Cytran, Inc.	Pharmaceutical angiostatic dipeptide compositions and method of use thereof
US5955430A (en)	1993-09-24	1999-09-21	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
AU758319B2 (en) *	1994-11-14	2003-03-20	University Of Southern California	Use of angiotensin II fragments and analogs thereof in tissue repair
US5834432A (en) *	1995-06-06	1998-11-10	The University Of Southern California	Use of angiotensin II Type 2 receptor agonists in tissue repair
US6528483B2 (en)	1995-06-07	2003-03-04	André Beaulieu	Method of producing concentrated non-buffered solutions of fibronectin
US7112320B1 (en)	1995-06-07	2006-09-26	Andre Beaulieu	Solid wound healing formulations containing fibronectin
US6110895A (en) *	1996-12-16	2000-08-29	University Of Southern California	Method of promoting healing in skin grafts
US6335195B1 (en)	1997-01-28	2002-01-01	Maret Corporation	Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
WO1998033813A2 (en) *	1997-02-04	1998-08-06	University Of Southern California	Method for accelerating healing of thermal injuries
US6248587B1 (en)	1997-11-26	2001-06-19	University Of Southern Cailfornia	Method for promoting mesenchymal stem and lineage-specific cell proliferation
US6165978A (en) *	1997-12-12	2000-12-26	University Of Southern California	Wound healing composition
EP1053004A2 (de)	1998-02-09	2000-11-22	University Of Southern California	Verwendung von angiotensin-analoga zur forderung der erythropoiesis
CA2323237C (en) *	1998-03-10	2009-05-19	University Of Southern California	Improved radiation therapy methods
US7173011B2 (en)	2000-11-20	2007-02-06	University Of Southern California	Radiation therapy methods
US6455500B1 (en)	1998-03-10	2002-09-24	University Of Southern California	Radiation therapy methods
AU3077299A (en)	1998-03-11	1999-09-27	University Of Southern California	Method of promoting production of living tissue equivalents
US6762167B1 (en)	1998-05-11	2004-07-13	University Of Southern California	Methods for treating a patient undergoing chemotherapy
EP1073453B1 (de) *	1998-05-11	2005-04-13	University Of Southern California	Verwendung von angiotensin analogen zur herstellung eines arzneimittels zur steigerung des ueberlebens der weissen blutzellen und mobilisierung von haematopoietischen stammzellen nach einer chemotherapeutischen behandlung
US6916783B2 (en) *	1998-07-13	2005-07-12	University Of Southern California	Methods for accelerating bone and cartilage growth and repair
ATE250423T1 (de)	1998-07-13	2003-10-15	Univ Southern California	Verfahren zur beschleunigen den zuwachs und heilen von knochen und knorpel
JP2002522505A (ja)	1998-08-13	2002-07-23	ユニヴァースティオブサザーンカリフォルニア	虚血組織への血流を増加させる方法
EP1158997A2 (de) *	1999-03-09	2001-12-05	University Of Southern California	Verfahren zür förderung der proliferation von mukellzellen und der herzbewebsheilung
AU756156B2 (en) *	1999-03-23	2003-01-02	University Of Southern California	Methods for limiting scar and adhesion formation
US6730775B1 (en)	1999-03-23	2004-05-04	University Of Southern California	Methods for limiting scar and adhesion formation
US7338938B2 (en)	1999-05-10	2008-03-04	University Of Southern California	Methods for treating a patient undergoing chemotherapy
US6821953B1 (en)	1999-12-16	2004-11-23	University Of Southern California	Methods for treating and preventing damage to mucosal tissue
US6747008B1 (en)	2000-06-19	2004-06-08	University Of Southern California	Methods for treating and preventing alopecia
US20020082222A1 (en)	2000-11-30	2002-06-27	Shapira Nathan Andrew	Treatments for neurogenetic disorders, impulse control disorder, and wound healing
WO2002087504A2 (en) *	2001-05-01	2002-11-07	University Of Southern California	Methods for inhibiting tumor cell proliferation
US20090227507A1 (en) *	2008-03-10	2009-09-10	University Of Southern California	Angiotensin (1-7) Dosage Forms and Uses Thereof
CN102858360B (zh)	2011-02-02	2017-07-25	南加利福尼亚大学	治疗糖尿病足溃疡的方法
US8557958B1 (en)	2012-06-18	2013-10-15	Tarix Pharmaceuticals Ltd.	Compositions and methods for treatment of diabetes
US8633158B1 (en)	2012-10-02	2014-01-21	Tarix Pharmaceuticals Ltd.	Angiotensin in treating brain conditions
JP6254692B2 (ja)	2013-07-03	2017-12-27	ジアリゾナボードオブリージェンツオンビハーフオブザユニヴァーシティーオブアリゾナ	認知機能不全を治療するための方法
US9333233B2 (en)	2014-02-25	2016-05-10	Tarix Pharmaceuticals Ltd.	Methods and compositions for the delayed treatment of stroke
US10183055B2 (en)	2014-07-21	2019-01-22	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides for the treatment of pain and other indications
US9796759B2 (en)	2014-07-21	2017-10-24	Arizona Board Of Regents On Behalf Of The University Of Arizona	Ang-(1-7) derivative oligopeptides and methods for using and producing the same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5015629A (en) *	1989-06-26	1991-05-14	University Of Southern California	Tissue repair

1994
- 1994-09-19 EP EP02028323A patent/EP1333034B1/de not_active Expired - Lifetime
- 1994-09-19 WO PCT/US1994/010502 patent/WO1995008565A1/en not_active Ceased
- 1994-09-19 CA CA002172494A patent/CA2172494A1/en not_active Abandoned
- 1994-09-19 DE DE69435301T patent/DE69435301D1/de not_active Expired - Lifetime
- 1994-09-19 AT AT02028323T patent/ATE473995T1/de not_active IP Right Cessation
- 1994-09-19 EP EP94929230A patent/EP0745091A4/de not_active Withdrawn
- 1994-09-19 JP JP7509852A patent/JPH09503205A/ja active Pending
- 1994-09-19 AU AU78364/94A patent/AU697504B2/en not_active Ceased
- 1994-09-21 ZA ZA947337A patent/ZA947337B/xx unknown
1996
- 1996-01-31 US US08/594,117 patent/US5716935A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
ZA947337B (en)	1995-05-10
AU697504B2 (en)	1998-10-08
EP1333034A1 (de)	2003-08-06
EP0745091A4 (de)	1998-05-20
US5716935A (en)	1998-02-10
CA2172494A1 (en)	1995-03-30
WO1995008565A1 (en)	1995-03-30
AU7836494A (en)	1995-04-10
JPH09503205A (ja)	1997-03-31
DE69435301D1 (de)	2010-08-26
EP1333034B1 (de)	2010-07-14
EP0745091A1 (de)	1996-12-04

Legal Events

Date	Code	Title	Description
2011-01-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE473995T1 (de)	2010-07-15	Verwendung von angiotensin-ii-analogen zur gewebewiederherstellung
DK0730465T3 (da)	2002-04-08	Anvendelse af angiotensin III og analoger dertil til vævsreparation
MX9703609A (es)	1997-08-30	Uso de fragmentos de angiotensina ii y analogos de la misma para la preparacion de composiciones en la preparacion de tejido.
ATE187646T1 (de)	2000-01-15	Verwendung von kupfer enthaltenden wirkstoffen zur beschleunigung der wundheilung
DE3881299D1 (de)	1993-07-01	Retinoide zur behandlung lichtgeschaedigter haut.
ATE88899T1 (de)	1993-05-15	Wundheilung und knochenregeneration.
ATE153648T1 (de)	1997-06-15	Verwendungen von alpha-hydroxyfettsäuren
ATE148338T1 (de)	1997-02-15	Desodorierende kosmetische zubereitungen mit einem gehalt an di- oder triglycerinestern
DE3752112D1 (de)	1997-10-02	Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen
ATE260658T1 (de)	2004-03-15	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
MD1688G2 (ro)	2002-01-31	Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
DK0479799T3 (da)	1997-08-25	Sårheling
DE59002863D1 (de)	1993-10-28	Lysolecithinderivate zur behandlung von autoimmunerkrankungen.
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
DE59407098D1 (de)	1998-11-19	Verwendung von diglycerinestern gegen unreine haut
MX9301387A (es)	1994-08-31	Metodo y composicion para el tratamiento de osteoporosis.
DK0550719T3 (da)	1997-09-01	Neutralt implanteringssystem
ES2134237T3 (es)	1999-10-01	Composiciones farmaceuticas que contienen acido ursodesoxicolico.
IL124431A0 (en)	1998-12-06	Sulfur containing dl-tert-butylphenol compounds useful as anti-inflammatory agents
BR0109139B1 (pt)	2013-09-03	composiÇÕes farmacÊuticas incluindo alginatos
DE59000195D1 (de)	1992-08-13	Pharmazeutisches praeparat zur behandlung von lebererkrankungen.
BR9002240A (pt)	1991-08-13	Processo para a preparacao de uma composicao conservada apropriada para aplicacao topica a pele e composicao
DK0569411T3 (da)	1995-08-28	Acylaminoalkylidenhydroxybiphosphonsyrer anvendelige til behandling af osteoartikulære sygdomme
MX9709983A (es)	1998-03-29	El uso de agonistas receptores tipo 2 de angiotesina ii en la preparacion de composiciones para la preparacion de tejidos.
ATE73812T1 (de)	1992-04-15	Thionophosphonsaeureester.